Rubix LS: Funding, Investors & Team (Oct 2026)
Our mission is to ensure that therapeutics and vaccines developed within the life science industry factor in every patient ethnicity and demographics to bolster product efficacy, health equity, and effective patient outcomes. At Rubix LS, we understand that practical therapeutic innovation doesn’t just happen within the lab; it occurs throughout the entire patient journey. Enabling better and diverse health outcomes starts by designing your early-stage development focus that encompasses various data sets.
Rubix LS has raised $1.3M across 1 funding round on record, the most recent a Seed of $1.3M announced in Feb 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rubix LS Company Profile and Key Stats
Latest funding round on record: Feb 2021.
Rubix LS Funding Rounds
Rubix LS Founders and Leadership Team
Contact details for the Rubix LS team: 1 of 1 has an email address on file.
Start 14-day free trial →Rubix LS Funding Compared to Other Biotechnology Startups
Rubix LS' latest round of $1.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rubix LS in Biotechnology and Lawrence
Companies Similar to Rubix LS
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Rubix LS Funding FAQs
What does Rubix LS do?
Our mission is to ensure that therapeutics and vaccines developed within the life science industry factor in every patient ethnicity and demographics to bolster product efficacy, health equity, and effective patient outcomes. At Rubix LS, we understand that practical therapeutic innovation doesn’t just happen within the lab; it occurs throughout the entire patient journey. Enabling better and diverse health outcomes starts by designing your early-stage development focus that encompasses various data sets.
How much funding has Rubix LS raised?
Rubix LS has raised $1.3M across 1 round on record. The most recent is a Seed of $1.3M announced in Feb 2021.
When did Rubix LS last raise funding?
Rubix LS' most recent funding round on record is a Seed of $1.3M, announced in Feb 2021.
Who is the CEO of Rubix LS?
Reginald Swift is listed as CEO at Rubix LS.
Where is Rubix LS headquartered?
Rubix LS is based in Lawrence, Massachusetts, United States.
How many employees does Rubix LS have?
Rubix LS is in the 11-50 employee band.
How does Rubix LS' funding compare to other Biotechnology startups?
Rubix LS' latest round of $1.3M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Rubix LS Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rubix LS is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.